- Home
- TVRD vs AGD Comparison
TVRD vs AGD Comparison
Compare TVRD & AGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVRD
- AGD
- Stock Information
- Founded
- TVRD 2017
- AGD 2006
- Country
- TVRD United States
- AGD United Kingdom
- Employees
- TVRD N/A
- AGD N/A
- Industry
- TVRD Biotechnology: Pharmaceutical Preparations
- AGD Trusts Except Educational Religious and Charitable
- Sector
- TVRD Health Care
- AGD Finance
- Exchange
- TVRD Nasdaq
- AGD Nasdaq
- Market Cap
- TVRD 246.5M
- AGD 255.9M
- IPO Year
- TVRD N/A
- AGD N/A
- Fundamental
- Price
- TVRD $25.77
- AGD $10.62
- Analyst Decision
- TVRD Strong Buy
- AGD
- Analyst Count
- TVRD 3
- AGD 0
- Target Price
- TVRD $60.67
- AGD N/A
- AVG Volume (30 Days)
- TVRD 56.7K
- AGD 61.2K
- Earning Date
- TVRD 05-13-2025
- AGD 01-01-0001
- Dividend Yield
- TVRD N/A
- AGD 8.13%
- EPS Growth
- TVRD N/A
- AGD N/A
- EPS
- TVRD N/A
- AGD N/A
- Revenue
- TVRD N/A
- AGD N/A
- Revenue This Year
- TVRD N/A
- AGD N/A
- Revenue Next Year
- TVRD N/A
- AGD N/A
- P/E Ratio
- TVRD N/A
- AGD N/A
- Revenue Growth
- TVRD N/A
- AGD N/A
- 52 Week Low
- TVRD $8.13
- AGD $8.20
- 52 Week High
- TVRD $34.31
- AGD $9.78
- Technical
- Relative Strength Index (RSI)
- TVRD N/A
- AGD 67.48
- Support Level
- TVRD N/A
- AGD $10.55
- Resistance Level
- TVRD N/A
- AGD $10.70
- Average True Range (ATR)
- TVRD 0.00
- AGD 0.09
- MACD
- TVRD 0.00
- AGD 0.01
- Stochastic Oscillator
- TVRD 0.00
- AGD 84.44
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About AGD abrdn Global Dynamic Dividend Fund of Beneficial Interest
Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current dividend income, more than 50% of which qualifies for the reduced federal income tax rate, as created by the Jobs and Growth Tax Relief Reconciliation Act of 2003. The fund also focuses on the long-term growth of capital as a secondary investment objective. The fund's portfolio holdings are in information technology, financials, health care, and consumer discretionary sectors among others.